Stop TB Partnership Website

Working Group on new TB Vaccines


Home | About us | Structure | TB vaccines | Meetings | Documents | Contact Us

Welcome to the Working Group on new TB Vaccines

<< April 2013 >>
Sun Mon Tue Wed Thu Fri Sat
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

Welcome to the Working Group on new TB Vaccines

The need for new TB vaccines

Safe and effective tuberculosis (TB) vaccines are urgently needed. TB continues to take the lives of almost one and a half million people per year and devastates the lives of millions more. New TB vaccines are an urgent part of a comprehensive plan to control and ulimately eliminate TB. Over the past decade, researchers have made significant progress in TB vaccine development, and a dozen TB vaccine candidates are now being evaluated in clinical trials. Read more...

The way forward, a strategic Blueprint for TB Vaccine Development

Developing new TB vaccines is a costly, complex and time-consuming undertaking that requires a coordinated global effort. Tuberculosis Vaccines: A Strategic Blueprint for the Next Decade provides a strategy to develop more effective TB vaccines as quickly and cost-effectively as possible. It was developed in consultation with stakeholders from the TB vaccine research community and outlines the major scientific challenges and priorities, critical activities and crucial questions that need to be addressed to develop these life-saving vaccines. Read more...

The Third Global Forum on TB Vaccines

The Third Global Forum on TB Vaccines, organised to discuss progress on TB vaccine development, will be held in Cape Town, South Africa from 24-27 March 2013, under the auspices of the Stop TB Partnership Working Group on New TB Vaccines. Co-ordinated by the South African Tuberculosis Vaccine Initiative (SATVI), TuBerculosis Vaccine Initiative (TBVI) and Aeras, the event will be hosted for the first time on the African continent, where TB disease rates are amongst the highest in the world. Read more...


TUBERCULOSIS VACCINES - A Strategic Blueprint for the Next Decade